Drug Patents owned by Padagis Us

1. List of Clindesse drug patents

CLINDESSE Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6899890 PADAGIS US Bioadhesive drug delivery system
Apr, 2023

(a month from now)

US9789057 PADAGIS US Pharmaceutical delivery system
Dec, 2026

(3 years from now)

Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient

Market Authorisation Date: 30 November, 2004

Treatment: Method of treating bacterial vaginosis

Dosage: CREAM;VAGINAL

How can I launch a generic of CLINDESSE before it's patent expiration?
More Information on Dosage

CLINDESSE family patents

11

United States

5

China

4

Australia

3

Brazil

3

Argentina

3

Korea, Republic of

3

Canada

3

Japan

3

European Union

1

Portugal

1

Singapore

1

Malaysia

1

Russia

1

Mexico

1

Peru

1

France

1

EA

1

South Africa

1

Hungary

1

Italy

2. List of Evamist drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6978945 PADAGIS US Dispensing device
Jul, 2022

(7 months ago)

Drugs and Companies using ESTRADIOL ingredient

Market Authorisation Date: 27 July, 2007

Treatment: NA

Dosage: SPRAY;TRANSDERMAL

More Information on Dosage

EVAMIST family patents

5

Australia

2

Korea, Republic of

2

New Zealand

2

Japan

1

Hungary

1

United States

1

Canada

1

Russia

1

Mexico

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic